Gilead Sciences Announces First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall St muted ahead of Nvidia results, hot inflation fuels rate-hike bets
- Oil falls as investors focus on Hormuz talks
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Boston Scientific discloses cybersecurity incident causing global disruption
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
Gilead Sciences (GILD) 'Crushed' the Quarter, Piper Jaffray Says; Remains Top Large-Cap Biotech Pick
May 1, 2015 7:10 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and lifted his price target on Gilead Sciences (NASDAQ: GILD) to $120.00 (from $116.00) after the company "crushed" the quarter and raised its outlook.
Schimmer commented, "GILD hosted the 1Q earnings call after the... More
Gilead Sciences (GILD) Bullish Stance Reiterated at Baird on 'Beat and Raise' Q1
May 1, 2015 6:42 AM EDTBaird analyst Brian Skorney reiterated an Outperform rating and $126 price target on Gilead Sciences (NASDAQ: GILD) following 'beat and raise' Q1.
Skorney commented, "A sizeable beat should be enough to support the stock and perhaps stop the sector slide. We expect... More
Gilead Sciences (GILD) Declares $0.43 Quarterly Dividend; 1.7% Yield
April 30, 2015 5:21 PM EDTGilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.43 per share, or $1.72 annualized.
The dividend will be payable on June 29, 2015, to stockholders of record on June 16, 2015, with an ex-dividend date of June 12, 2015.
The annual yield on the dividend is 1.7... More
Gilead Sciences (GILD) Tops Q1 EPS by 48c, Raises FY Revenue Guidance
April 30, 2015 4:02 PM EDTGilead Sciences (NASDAQ: GILD) reported Q1 EPS of $2.76, $0.48 better than the analyst estimate of $2.28. Revenue for the quarter came in at $7.59 billion versus the consensus estimate of $6.81 billion.
Gilead Sciences sees FY2015 revenue of $28-29 million, versus the consensus of $28.50... More
